Houston-based CRO, CEBIS, has announced its expansion into the North American and Indian markets after operating for 15 years in the EU. The company will provide a range of services including clinical research, preclinical testing, drug safety services, biostatistics, and software solutions. CEBIS has merged with several other clinical trial industry representatives to meet the objectives of its sponsors. With operations in Boston, Philadelphia, Chicago, and technology centers in India, CEBIS is well-positioned to become a major player in the global clinical research environment.
Source: Link